UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$948M |
| 2 |
Snowflake
SNOW
|
+$542M |
| 3 |
Sea Limited
SE
|
+$501M |
| 4 |
Procter & Gamble
PG
|
+$491M |
| 5 |
Snap
SNAP
|
+$403M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$434M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$350M |
| 3 |
Lowe's Companies
LOW
|
+$215M |
| 4 |
Applied Materials
AMAT
|
+$186M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.21% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 12.28% |
| 5 | Communication Services | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Liberty Energy
LBRT
$3.25B
| $863K | ﹤0.01% |
71,147
+961
| +1% | +$10.7K |
|
|
ATRI
2202
DELISTED
Atrion Corp
ATRI
| $861K | ﹤0.01% |
1,234
| – | – |
|
|
AVID
2203
DELISTED
Avid Technology Inc
AVID
| $860K | ﹤0.01% |
29,726
+8,785
| +42% | +$271K |
|
|
KYNB
2204
Kyntra Bio
KYNB
$29.4M
| $860K | ﹤0.01% |
3,364
+74
| +2% | +$26.2K |
|
2205
OptimizeRx
OPRX
$133M
| $858K | ﹤0.01% |
10,035
+233
| +2% | +$14.6K |
|
2206
National Healthcare
NHC
$3.38B
| $858K | ﹤0.01% |
12,255
+2,397
| +24% | +$174K |
|
|
CAI
2207
DELISTED
CAI International, Inc.
CAI
| $856K | ﹤0.01% |
15,304
+2,924
| +24% | +$163K |
|
|
AAN
2208
DELISTED
The Aaron's Company Inc
AAN
| $855K | ﹤0.01% |
31,037
+4,450
| +17% | +$125K |
|
2209
Columbia Financial
CLBK
$1.13B
| $853K | ﹤0.01% |
46,125
| – | – |
|
|
KE
2210
Kimball Electronics
KE
$628M
| $853K | ﹤0.01% |
33,108
+217
| +0.7% | +$4.96K |
|
2211
Helix Energy Solutions
HLX
$1.41B
| $848K | ﹤0.01% |
218,534
| – | – |
|
2212
Heritage Financial
HFWA
$1.21B
| $848K | ﹤0.01% |
33,251
| – | – |
|
2213
Mativ Holdings
MATV
$711M
| $848K | ﹤0.01% |
24,460
| – | – |
|
2214
CEVA Inc
CEVA
$1.08B
| $845K | ﹤0.01% |
19,811
| – | – |
|
2215
Acco Brands
ACCO
$407M
| $845K | ﹤0.01% |
98,408
+24,143
| +33% | +$213K |
|
|
HSII
2216
DELISTED
Heidrick & Struggles
HSII
| $843K | ﹤0.01% |
18,897
+4,330
| +30% | +$183K |
|
2217
uniQure
QURE
$3.22B
| $840K | ﹤0.01% |
26,240
+386
| +1% | +$11.8K |
|
2218
Interface
TILE
$2.22B
| $837K | ﹤0.01% |
55,253
| – | – |
|
|
LOVE
2219
LoveSac
LOVE
$261M
| $832K | ﹤0.01% |
12,586
+2,845
| +29% | +$178K |
|
2220
Ichor Holdings
ICHR
$2.56B
| $827K | ﹤0.01% |
20,135
| – | – |
|
2221
Universal Corp
UVV
$1.27B
| $826K | ﹤0.01% |
17,100
-168
| -1% | -$8.53K |
|
|
AGEN
2222
Agenus
AGEN
$290M
| $825K | ﹤0.01% |
8,005
-1,654
| -17% | -$187K |
|
2223
Anika Therapeutics
ANIK
$287M
| $819K | ﹤0.01% |
19,238
+3,253
| +20% | +$134K |
|
2224
Ethan Allen Interiors
ETD
$603M
| $817K | ﹤0.01% |
34,486
+6,401
| +23% | +$158K |
|
2225
The Joint Corp
JYNT
$119M
| $817K | ﹤0.01% |
8,337
+341
| +4% | +$31.9K |
|
Similar funds
UBS AM's Q3 2021 Portfolio in Review
As of Q3 2021, UBS AM held 2,809 positions worth $241B, up 3.2% from $234B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM deployed $8.13B of net new capital in Q3 2021, opening 56 new positions and adding to 1,358 existing holdings. Its largest new stake was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Infosys, an estimated $434M trimmed.
- UBS AM's largest Q3 2021 buy was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
- UBS AM added most to Microsoft in Q3 2021, an estimated $948M increase.
- UBS AM's biggest Q3 2021 reduction was Infosys, cutting an estimated $434M.
- UBS AM fully exited Vanguard Short-Term Treasury ETF in Q3 2021, selling an estimated $350M.
- UBS AM's ten largest holdings make up 22% of its $241B portfolio in Q3 2021.
- UBS AM opened 56 new positions and closed 62 in Q3 2021.
- UBS AM's portfolio value rose 3.2% quarter-over-quarter to $241B.
Based on UBS AM's 13F filing for Q3 2021, filed 15 Nov 2021.